# Tarsons Products share price today (Tarsons Products Ltd, NSE: TARSONS)

> Tarsons Products share price today: ₹297.55 at the NSE close on 3 November 2026, up 2.9% in a year. Tarsons Products (NSE: TARSONS) is worth ₹1,583 crore, trades at a P/E of 133.9 and has closed between ₹176.63 and ₹360.30 over the past 52 weeks. > Tarsons Products Ltd's share price has risen faster than its earnings: +2.9% in a year, against −52.0% for earnings per share. TARSONS · Medical Equipment · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/tarsons-products-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Getting worse, from the last 12 quarters
- Price: ₹297.55 (+2.9% in a year)
- P/E: 133.9× (higher than 95% of the last 4.9 years)
- Revenue (Jun 2026): ₹110 Cr (+20.7% on a year ago)
- Profit (Jun 2026): −₹1.4 Cr (−180.9% on a year ago)
- Operating margin: 23.6% (−3.5 points on a year ago)
- ROCE: 5%, FY26
- ROIC: 1.0%, against a 12.0% cost of capital: −11.0 points

The main question: the share price moved +2.9% in a year while yearly earnings per share moved −52.0%. The difference came from the market paying a higher multiple. ## What is the Tarsons Products share price today? Tarsons Products Ltd's share price was ₹297.55 at the close on 3 November 2026. It has been rising for 15 weeks. That is 3.6% above its average price over the last 200 trading days. In the last 52 weeks it traded between ₹177 and ₹360, and at that close it sat 66% of the way up from that low. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 1 week running. Over the last 4.9 years the share price moved −64% while the NIFTY 500 moved +48%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 30 October 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Tarsons Products this quarter? Three changes stood out: revenue up on a year earlier for 7 quarters in a row (every quarter we can compare), profit down on a year earlier for 7 quarters in a row (every quarter we can compare) and lowest operating margin in 8 quarters. 1. Revenue up on a year earlier for 7 quarters in a row (every quarter we can compare) In the June 2026 quarter revenue was ₹110 crore, +20.7% on a year earlier. Why: US orders that had been paused by tariffs started coming back, and some turned into large orders. Next results: check whether US inquiries keep turning into orders and can withstand more tariff or trade trouble. From the earnings call on 30 Sep 2026. 2. Profit down on a year earlier for 7 quarters in a row (every quarter we can compare) In the June 2026 quarter profit was ₹-1 crore, -180.9% on a year earlier. Why: Profit fell because raw material costs rose and the company could not fully pass them on to domestic customers. Next results: check whether gross margin, the profit left after raw material costs, gets back to the 65% to 67% range management mentioned. From the earnings call on 30 Sep 2026. 3. Lowest operating margin in 8 quarters Operating margin was 23.6% in the June 2026 quarter, against 27% a year earlier. Why: The company kept less profit from each sale because it absorbed a big rise in raw material costs, passed only part of it to domestic customers, and left export prices unchanged. From the earnings call on 30 Sep 2026. ## What are Tarsons Products' latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), Tarsons Products reported revenue of ₹110 crore, up 20.7% from ₹91.4 crore a year earlier, and a loss of ₹1.44 crore, down 180.9% from ₹1.78 crore. ### Tarsons Products results: April to June 2026 against a year earlier

| Measure | April to June 2026 | April to June 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹110 crore | ₹91.4 crore | +20.7% |
| Profit | loss of ₹1.44 crore | ₹1.78 crore | −180.9% |
| Earnings per share | ₹−0.27 | ₹0.33 | −181.8% |
| Operating margin | 23.6% | 27.0% | −3.5 points |

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). Tarsons Products' management discussed these results on a call held on 30 September 2026; what it said is further down this page. (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.)

## What is the Tarsons Products share price history? Tarsons Products closed at ₹297.55 on 3 November 2026, up 2.9% from ₹289.05 a year earlier (31 October 2025) and down 63.6% over five years. Its highest weekly close since November 2021 was ₹871.10 on 16 September 2022. ### Tarsons Products share price: then and now

| When | Close | Change to 3 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 23 Oct 2026 | ₹300.00 | −0.8% |
| 1 month ago · 1 Oct 2026 | ₹329.40 | −9.7% |
| 6 months ago · 30 Apr 2026 | ₹219.92 | +35.3% |
| 1 year ago · 31 Oct 2025 | ₹289.05 | +2.9% |
| 3 years ago · 3 Nov 2023 | ₹481.60 | −38.2% |
| 5 years ago · 26 Nov 2021 | ₹818.40 | −63.6% |
| Earliest weekly close in our records · 26 Nov 2021 | ₹818.40 | −63.6% |
| Highest weekly close since November 2021 · 16 Sep 2022 | ₹871.10 | −65.8% |
| Lowest weekly close since November 2021, also the 52-week low · 27 Mar 2026 | ₹176.63 | +68.5% |
| 52-week high (weekly close) · 14 Aug 2026 | ₹360.30 | −17.4% |

Weekly closing prices. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (263 weekly closes from 26 November 2021 to 3 November 2026.)

## What is the latest news on Tarsons Products? 3 Nov 2026: Tarsons Products closed at ₹297.55, down 0.8% on the week and down 9.7% on the month. 30 Sep 2026: Tarsons Products held its results call for April to June 2026. Management guided: Q2 gross margin 65%-67%, with full recovery not yet achieved. ### Earlier

- Results for April to June 2026: Revenue up 20.7% and profit down 180.9% on a year earlier. ## What dividend does Tarsons Products pay? Tarsons Products paid no dividend in the 12 months to 4 November 2026. The last was a dividend of ₹2 a share, ex-date 20 September 2024. ### Tarsons Products dividends since 1 April 2021

| Ex-date | Dividend per share | Type |
| --- | --- | --- |
| 20 Sep 2024 | ₹2 | Dividend |

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here. 1 of 5 Of the last 5 financial years, years with an NSE dividend record

Not in its latest year. Tarsons Products Ltd paid out 0% of its profit as dividends in FY26. It did pay a dividend in 1 of its last 5 reported years, so there is a history but no current dividend. (From the NSE corporate-actions record, read 4 November 2026.)

## What did Tarsons Products management say on the latest results call? On the call for April to June 2026, held on 30 September 2026, Tarsons Products' management guided: Q2 gross margin 65%-67%, with full recovery not yet achieved. > “If a 100% tariff becomes a reality, I am sorry to say that there will be no trade between India and the US, not only for our business but for other businesses as well.”
> Santosh Agarwal, CFO, on the call for April to June 2026

### What management guided

- New facilities to reach full utilization in 3-5 years and generate additional revenue of ₹400-450 crore. - New-capital spending gross margin 65%-70%; company operating margin 35%-37% if utilization reaches 65%-70% and growth stays 15%-20%, barring disruption or price decline. - ROCE and ROE 17%-18% after full utilization, potentially after 3-4 years. - Debt repayment of ₹60-70 crore annually; all debt repaid within 3-4 years if 15% annual growth continues. Management’s own plans and goals, from our notes of the call. A plan is not a result. Source: [the call transcript](https://files.tijoristack.ai/concall/transcript/44920-30-Sep-2026.pdf). (From the call for April to June 2026, 30 September 2026.)

## What to watch in Tarsons Products' next results? When Tarsons Products reports July to September 2026, these are the 4 checks that show whether the story is still on course. First: Q2 gross-margin range and raw-material pass-through - check whether partial recovery progresses. - What to check (from the call)
- Q2 gross-margin range and raw-material pass-through - check whether partial recovery progresses. - Panchla and Amta operationalization by year-end - check whether remaining CWIP begins converting into revenue. - US inquiry conversion and export order momentum - check resilience against further tariff or geopolitical disruption. - Nerbe product approvals and cross-supply - check whether strategic synergies start after organic capital spending completion. ## Which stock lists is Tarsons Products on? Tarsons Products is not on any of our India lists this week. ## Is Tarsons Products profitable? Tarsons Products Ltd posted a net loss of ₹1.4 Cr in the Jun 2026 quarter. Full-year FY26 profit was ₹14.0 Cr. Over 5 years profit has grown −27.3% a year on average. That loss is 1.3% of the quarter's revenue. The same quarter a year earlier earned ₹1.8 Cr. 1 of the last 12 reported quarters were loss-making. Jun 2026 profit was −₹1.4 Cr, −180.9% on a year earlier. For the full year, FY26 profit was ₹14.0 Cr (−53.3% on the year before). Why profit moved: revenue changed +20.7% on a year earlier and the margin moved −3.5 percentage points. Sales did the work while the margin got thinner. On average over the last four quarters, profit changed −78.0% and revenue +11.0%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does Tarsons Products make, and is it growing? Tarsons Products Ltd reported ₹110 Cr of revenue in the Jun 2026 quarter, +20.7% on the same quarter a year earlier. That is the 7th quarter in a row with growth on the year before. Over 5 years it has grown 13.1% a year on average. The last full year, FY26, came in at ₹423 Cr. The last four reported quarters add to ₹441 Cr. FY26 revenue was ₹423 Cr, +7.9% on the year before. Recent pace: the last four quarters grew +11.0% on average, against 13.1% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +10.6%, against +14.4% a year over the last 8 quarters (rolling over); profit over the last 12 months grew −59.7%, against −54.5% a year (rolling over). ## How much of every ₹100 of sales does Tarsons Products keep? Tarsons Products Ltd's operating margin was 23.6% in the Jun 2026 quarter, 3.5 percentage points lower than the same quarter a year ago. Across 5 years it has been between 28.0% and 51.0%. The latest quarter is below every full year in that period. Why the margin moved: operating margin changed −3.5 percentage points on the year while gross margin changed −3.0 points. So the drop came mostly from the gross margin, which means input costs and prices charged. ## Is Tarsons Products' profit turning into cash? Over the last 3 years, 385% of Tarsons Products Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹118 Cr of operating cash against ₹14.0 Cr of profit. After ₹220 Cr of spending on assets, free cash was −₹102 Cr: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 385% of profit came in as cash: the cash cycle got 44 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives. What to look at next: the bigger use of cash is spending on new assets, at 3.0× depreciation over three years. The next section checks what that spending is building. ## Where does Tarsons Products' cash go? Tarsons Products Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 361 days in FY26, up from 317 days in FY21. It spent ₹549 Cr on assets over the last 3 years. Customers take 74 days to pay, and stock sits for 341 days on average. At FY26 sales of ₹423 Cr, each day of that cycle ties up about ₹1.2 Cr, so roughly ₹418 Cr is tied up in the business at any time. FY26: customers took 74 days to pay and stock sat for 341 days, about 11.2 months of sales sitting as stock, for a full cycle of 361 days, longer than FY21's 317. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 341 days. Customers pay about 74 days after that. Suppliers are paid at 53 days. Together that makes the 361-day cycle. Spending on assets: ₹549 Cr over the last 3 years, against ₹181 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹159 Cr (FY26): assets paid for that are not earning yet. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Tarsons Products' P/E ratio, and how does it compare with its own history? Tarsons Products Ltd's P/E is 133.9×, near the high end of its own history: higher than 95% of past readings. Its usual P/E (the middle reading) is 49.0×, over 4.9 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. The P/E here, and its history, use a profit figure that can leave out one-off items, so it can differ from a P/E worked out on the quarterly results. Those results' earnings per share for the four quarters to Jun 2026 add up to ₹2.09. Why the multiple is where it is: over the past year earnings per share moved −52.0% while the price moved +2.9%. The price did better than earnings, which pushed the multiple up within its own range. Where the price move came from: over 5 years the price moved −18.3% a year; about −29.7% a year came from earnings growth and about +11.4 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Tarsons Products business getting better or worse? Tarsons Products Ltd's business is getting worse. Profit and EPS growth are shrinking: profit growth is −59.7% in the latest quarter, against −32.0% at its best in 12 quarters, with ROCE steady at 4.5%. This is based on 12 quarters of 4 measures. Why it matters: falling lines mean any ratio below that looks low should be read with that direction in mind. ## How much does Tarsons Products earn on its capital? Tarsons Products Ltd earned a ROCE of 5% in FY26. Its return on capital used (ROIC) is 11.0 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 3.3% net margin and 0.36× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 3.3% net margin × 0.36× asset turnover × 1.87× leverage (assets divided by equity) ≈ 2.2% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: 1.0% − 12.0% = −11.0 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. ## Does Tarsons Products have too much debt? Tarsons Products Ltd has total debt of ₹393 Cr against shareholder equity of ₹635 Cr as of Jun 2026, so its debt is 0.62× its equity. Year by year, that ratio went from 0.04 in FY22 to 0.62 in FY26. Keep that borrowing in mind when reading the returns on this page. ## What is the Tarsons Products shareholding pattern? Foreign institutions cut their stake in Tarsons Products Ltd by 7.5 percentage points over 8 quarters, the biggest change among its owners. Foreign institutions now own 0.6% of the company. Domestic institutions moved +0.4 points over the same period, to 0.6%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Foreign institutions: −7.5 points over 8 quarters, to 0.6%; Domestic institutions: +0.4 points over 8 quarters, to 0.6%; Promoters: +0.0 points over 8 quarters, to 47.3%. Why the owners changed: foreign institutions drove it (−7.5 points). They reduced their stake. ## How far is Tarsons Products from balance-sheet trouble? For Tarsons Products Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Tarsons Products rank in its industry? 29.5 out of 100, rank 4 of 6 in Medical Equipment, with 75% of the evidence available. Tarsons Products Ltd scores 29.5 out of 100 against the 6 companies it is compared with in Medical Equipment, ranking 4. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 5.8 + 6.6 + 5.4 + 11.7 = 29.5. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Tarsons Products compared with? Tarsons Products ranks 4 of 6 Medical Equipment companies on the 4-Factor Sector Score, with 29.5 out of 100. 1. [Laxmi Dental Ltd](https://www.sectoralpha.in/stocks/laxmi-dental-ltd) LAXMIDENTL · quiet · Evidence leans up · 68% evidence 53.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.4/35 · Revenue 16.7% · Profit 34.8% · Operating margin change 1 points · 100% evidence Capital efficiency 14.5/25 · ROCE 15% · Operating margin 19% · 100% evidence Valuation 10.9/20 · P/E 28.1× · PEG n/a · 15% evidence Relative strength 7.5/20 · Lead over its industry n/a · Lead over NIFTY 500 -13.9% · 1 year -43.5% · 25% evidence · 0 of 12 weeks ahead Exact sum: 20.4 + 14.5 + 10.9 + 7.5 = 53.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [Vasa Denticity Ltd](https://www.sectoralpha.in/stocks/vasa-denticity-ltd) DENTALKART · breaking out · Evidence leans down · 75% evidence 35.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 14.3/35 · Revenue 17.9% · Profit -30.2% · Operating margin change 1.1 points · 100% evidence Capital efficiency 4.6/25 · ROCE 7% · Operating margin 6.1% · 100% evidence Valuation 6.9/20 · P/E 65× · PEG n/a · 50% evidence Relative strength 9.9/20 · Lead over its industry n/a · Lead over NIFTY 500 -0.8% · 1 year -27.7% · 25% evidence · 8 of 12 weeks ahead Exact sum: 14.3 + 4.6 + 6.9 + 9.9 = 35.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Poly Medicure Ltd](https://www.sectoralpha.in/stocks/poly-medicure-ltd) POLYMED · quiet · Most evidence points down · 100% evidence 31.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.5/35 · Revenue 18.4% · Profit -12.3% · Operating margin change -2 points · 100% evidence Capital efficiency 13.3/25 · ROCE 12.5% · Operating margin 24% · 100% evidence Valuation 5.2/20 · P/E 45.9× · PEG 3.87 · 100% evidence Relative strength 0.9/20 · Lead over its industry -19.9% · Lead over NIFTY 500 -4.6% · 1 year -27.5% · 100% evidence · 6 of 12 weeks ahead Exact sum: 12.5 + 13.3 + 5.2 + 0.9 = 31.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. Tarsons Products Ltd this page TARSONS · losing its lead · Most evidence points down · 75% evidence 29.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 5.8/35 · Revenue 10.6% · Profit -59.7% · Operating margin change -3.5 points · 100% evidence Capital efficiency 6.6/25 · ROCE 4.6% · Operating margin 23.6% · 100% evidence Valuation 5.4/20 · P/E 131× · PEG n/a · 50% evidence Relative strength 11.7/20 · Lead over its industry n/a · Lead over NIFTY 500 22.2% · 1 year 0.7% · 25% evidence · 10 of 12 weeks ahead Exact sum: 5.8 + 6.6 + 5.4 + 11.7 = 29.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Prevest Denpro Ltd](https://www.sectoralpha.in/stocks/prevest-denpro-ltd) PREVEST · Too little evidence to rank firmly · 43% evidence 64.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.5/43.75 · Revenue 17.3% · Profit 17% · Operating margin change -0.6 points · 53% evidence Capital efficiency 23.6/31.25 · ROCE 25.2% · Operating margin 33.9% · 57% evidence Valuation 17.3/25 · P/E 24.8× · PEG n/a · 50% evidence Relative strength: no reading this week · its 20 points are shared across the other three Exact sum: 23.5 + 23.6 + 17.3 = 64.4 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 6. [Hemant Surgical Industries Ltd](https://www.sectoralpha.in/stocks/hemant-surgical-industries-ltd) breaking out · Too little evidence to rank firmly · 48% evidence 60.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.0/35 · Revenue 57.2% · Profit 52.9% · Operating margin change -1 points · 48% evidence Capital efficiency 15.6/25 · ROCE 18.9% · Operating margin 9% · 95% evidence Valuation 9.7/20 · P/E 49.2× · PEG n/a · 15% evidence Relative strength 12.5/20 · Lead over its industry n/a · Lead over NIFTY 500 67.5% · 1 year n/a · 25% evidence · 8 of 12 weeks ahead Exact sum: 23 + 15.6 + 9.7 + 12.5 = 60.8 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Jun 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Medical Equipment](https://www.sectoralpha.in/sectors/medical-equipment), all 6 compared on one page. ## Which companies are close to Tarsons Products in size? Tarsons Products is the 2nd largest of 6 Medical Equipment companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Poly Medicure. Just below it: Laxmi Dental, Hemant Surgical Industries, Vasa Denticity and Prevest Denpro. ### Medical Equipment companies close in size

1. [Poly Medicure Ltd](https://www.sectoralpha.in/stocks/poly-medicure-ltd) ₹14,692 crore
2. Tarsons Products Ltd ₹1,548 crore
3. [Laxmi Dental Ltd](https://www.sectoralpha.in/stocks/laxmi-dental-ltd) ₹977 crore
4. [Hemant Surgical Industries Ltd](https://www.sectoralpha.in/stocks/hemant-surgical-industries-ltd) ₹834 crore
5. [Vasa Denticity Ltd](https://www.sectoralpha.in/stocks/vasa-denticity-ltd) ₹754 crore
6. [Prevest Denpro Ltd](https://www.sectoralpha.in/stocks/prevest-denpro-ltd) ₹510 crore

[All 6 Medical Equipment companies, largest first](https://www.sectoralpha.in/sectors/medical-equipment#all-companies)

### Companies close in size in other industries

1. [Studds Accessories Ltd](https://www.sectoralpha.in/stocks/studds-accessories-ltd) ₹1,551 crore · Plastics - Others
2. [Menon Bearings Ltd](https://www.sectoralpha.in/stocks/menon-bearings-ltd) ₹1,548 crore · Bearings
3. Tarsons Products Ltd ₹1,548 crore
4. [NELCO Ltd](https://www.sectoralpha.in/stocks/nelco-ltd) ₹1,543 crore · Telecom Services
5. [Dynamic Cables Ltd](https://www.sectoralpha.in/stocks/dynamic-cables-ltd) ₹1,542 crore · Cables - Power

## What else do people ask about Tarsons Products? ### What is Tarsons Products's share price today? Tarsons Products Ltd's share price is ₹297.55, +2.9% over the past year. The whole company is worth ₹1,583 Cr on the market. In the last 52 weeks it traded between ₹177 to ₹360; today it is 66% of the way up from the low, 3.6% above its 200-day average (as of 3 November 2026). ### What were Tarsons Products's latest quarterly results? Tarsons Products Ltd reported revenue of ₹110 Cr and a net loss of ₹1.4 Cr for the Jun 2026 quarter. Revenue rose 20.7% and profit fell 180.9% compared with a year earlier. Earnings per share were −₹0.27. The operating margin was 23.6%, 3.5 percentage points lower than a year earlier (as of 3 November 2026). ### What is Tarsons Products's market cap? Tarsons Products Ltd's market capitalisation is ₹1,583 Cr at a share price of ₹297.55. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Tarsons Products performing? Tarsons Products Ltd's share price has been rising for 15 weeks. In its latest quarter, revenue rose 20.7% and profit fell 180.9% compared with a year earlier. Over the past 13 weeks it has done worse than the NIFTY 500, for 1 week running (as of 3 November 2026). ### Will Tarsons Products's share price go up? This page does not forecast Tarsons Products Ltd's share price. What it shows instead: the share price is ₹297.55, and it has been rising for 15 weeks. Its P/E of 133.9× is higher than 95% of its own last 5 years (as of 3 November 2026). ### Who owns Tarsons Products? Promoters own 47.3% of Tarsons Products Ltd, foreign institutions 0.6%, domestic institutions 0.6% and the public 51.5% (latest quarter). The biggest change over the last two years: Foreign institutions cut their stake by 7.5 percentage points over 8 quarters (as of 3 November 2026). ### Where is Tarsons Products in its business cycle? Tarsons Products Ltd's FY26 operating margin was 28.0%, against a 5-year range of 28.0% to 51.0%: the low end of its own range, which is often where recoveries start. The latest quarter was 23.6%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Tarsons Products story? The main question: the share price moved +2.9% in a year while yearly earnings per share moved −52.0%. The difference came from the market paying a higher multiple. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Tarsons Products a stock worth studying right now? What the numbers show: Tarsons Products Ltd's share price has risen faster than its earnings: +2.9% in a year, against −52.0% for earnings per share. The main open question: whether earnings grow into a price that has already moved. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ### Is there a Tarsons Products share price forecast for 2026? What management itself guided: Q2 gross margin 65%-67%, with full recovery not yet achieved. This is research, not advice. We’re not SEBI-registered.